Share Price and Basic Stock Data
Last Updated: January 3, 2026, 1:04 pm
| PEG Ratio | 4.08 |
|---|
Analyst Insight & Comprehensive Analysis
AI Stock Ranker – Real-Time Fundamental Strength Score
Business Overview and Revenue Trends
Aplab Ltd operates in the instrumentation and process control sector, with its current stock price reported at ₹77.8 and a market capitalization of ₹178 Cr. The company has demonstrated fluctuating revenue trends over recent quarters. For instance, sales rose from ₹10.56 Cr in September 2022 to ₹18.49 Cr in March 2023 but saw a decline to ₹9.11 Cr in June 2023. However, sales rebounded to ₹10.88 Cr in September 2023, indicating a recovery phase. Year-on-year, total sales for FY 2025 are reported at ₹63.67 Cr, compared to ₹51.48 Cr for FY 2023, showcasing a growth trajectory. The trailing twelve months (TTM) sales stand at ₹72.67 Cr, indicating a robust performance recently. Despite these improvements, the quarterly sales volatility raises concerns about sustained revenue generation. The company’s ability to maintain these trends will be critical for its future growth prospects.
Profitability and Efficiency Metrics
Profitability metrics for Aplab Ltd reveal a challenging landscape. The reported net profit for FY 2025 stood at ₹0.26 Cr, a decrease from ₹0.20 Cr in FY 2023. The company’s operating profit margin (OPM) fluctuated significantly, reaching a peak of 39.05% in March 2023 but declining to -12.52% for FY 2025. This volatility reflects operational inefficiencies, compounded by rising expenses, which reached ₹71.64 Cr in FY 2025. The company’s return on equity (ROE) is low at 2.95%, while the return on capital employed (ROCE) stands at 8.82%, both of which are below sector averages. The cash conversion cycle (CCC) is reported at 219.18 days, suggesting challenges in working capital management. Overall, while there have been peaks in profitability, the inconsistency in earnings and efficiency metrics indicates significant operational hurdles that need addressing.
Balance Sheet Strength and Financial Ratios
Aplab Ltd’s balance sheet presents a mixed picture. The total liabilities as of September 2025 are reported at ₹68.50 Cr, with borrowings amounting to ₹26.81 Cr, indicating a manageable debt level relative to its assets. The company’s reserves have shown a positive turn, increasing to ₹3.20 Cr in September 2025 from negative figures in previous years. However, the interest coverage ratio (ICR) remains concerning at -0.39x, suggesting that Aplab Ltd is struggling to meet its interest obligations. The price-to-book value (P/BV) ratio stands at -2.24x, indicating that the market is valuing the company’s assets unfavorably. This could deter potential investors. The company’s financial ratios, including the current ratio of 0.39x, suggest liquidity challenges, which could affect its operational flexibility. Overall, while there are improvements in reserves, the high debt and poor liquidity ratios raise red flags for investors.
Shareholding Pattern and Investor Confidence
The shareholding pattern of Aplab Ltd reveals significant changes over recent months. The promoters held 43.83% of the company as of September 2025, a notable decline from a high of 67.61% in December 2024. This reduction in promoter holding could signal a lack of confidence in the company’s future prospects. In contrast, the public stake has increased to 56.16%, indicating a rising interest among retail investors. Institutional investments remain minimal, with foreign institutional investors (FIIs) not reported and domestic institutional investors (DIIs) holding only 0.01%. The total number of shareholders has risen to 5,619, reflecting growing public interest, yet the declining promoter stake may raise concerns about long-term governance and strategic direction. Investor confidence appears mixed, with increased public participation juxtaposed against the reduced confidence of the promoters.
Outlook, Risks, and Final Insight
The outlook for Aplab Ltd presents both opportunities and risks. The company has shown the potential for revenue growth, with a TTM sales figure of ₹72.67 Cr, indicating an upward trajectory. However, significant risks persist, including operational inefficiencies reflected in fluctuating profit margins and a troubling interest coverage ratio. The company’s high cash conversion cycle suggests challenges in managing working capital, which could hinder its ability to capitalize on growth opportunities. Additionally, the declining promoter shareholding raises questions about governance and future strategic decisions. Aplab Ltd must focus on stabilizing its profitability and improving operational efficiencies to regain investor confidence. If these challenges are addressed, the firm could leverage its growth potential in the instrumentation sector, but failure to do so may result in stagnant performance and further investor skepticism.
Source: Getaka Fundamental Analysis | Generated using proprietary financial data.
Competitors
| Stock Name ⇩ | Market Cap ⇩ | Current Price ⇩ | High / Low ⇩ | Stock P/E ⇩ | Book Value ⇩ | Dividend Yield ⇩ | ROCE ⇩ | ROE ⇩ | Face Value ⇩ |
|---|---|---|---|---|---|---|---|---|---|
| Aplab Ltd | 178 Cr. | 77.8 | 93.0/28.2 | 163 | 7.53 | 0.00 % | 8.82 % | 2.95 % | 10.0 |
| Industry Average | 178.00 Cr | 77.80 | 163.00 | 7.53 | 0.00% | 8.82% | 2.95% | 10.00 |
Quarterly Result
| Metric | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 10.56 | 11.54 | 18.49 | 9.11 | 10.88 | 11.93 | 17.61 | 9.93 | 13.86 | 15.94 | 23.93 | 15.45 | 17.35 |
| Expenses | 11.49 | 10.54 | 11.27 | 8.34 | 9.34 | 11.19 | 15.88 | 9.10 | 13.26 | 23.94 | 25.33 | 13.71 | 14.29 |
| Operating Profit | -0.93 | 1.00 | 7.22 | 0.77 | 1.54 | 0.74 | 1.73 | 0.83 | 0.60 | -8.00 | -1.40 | 1.74 | 3.06 |
| OPM % | -8.81% | 8.67% | 39.05% | 8.45% | 14.15% | 6.20% | 9.82% | 8.36% | 4.33% | -50.19% | -5.85% | 11.26% | 17.64% |
| Other Income | 0.07 | -0.41 | 0.06 | 0.06 | 0.06 | 0.05 | -0.03 | 0.06 | 1.88 | 0.46 | 2.69 | 0.19 | 0.08 |
| Interest | 0.66 | 0.75 | 0.93 | 0.67 | 1.35 | 0.33 | 1.09 | 0.67 | 0.82 | 0.77 | 0.95 | 0.68 | 0.95 |
| Depreciation | 0.12 | 0.12 | 0.08 | 0.14 | 0.11 | 0.08 | 0.12 | 0.12 | 0.13 | 0.10 | 0.13 | 0.12 | 0.11 |
| Profit before tax | -1.64 | -0.28 | 6.27 | 0.02 | 0.14 | 0.38 | 0.49 | 0.10 | 1.53 | -8.41 | 0.21 | 1.13 | 2.08 |
| Tax % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | -3,252.38% | 24.78% | 22.60% |
| Net Profit | -1.64 | -0.28 | 6.27 | 0.02 | 0.14 | 0.38 | 0.49 | 0.10 | 1.53 | -8.41 | 7.04 | 0.85 | 1.61 |
| EPS in Rs | -0.82 | -0.14 | 3.14 | 0.01 | 0.06 | 0.17 | 0.22 | 0.05 | 0.69 | -3.35 | 2.80 | 0.34 | 0.64 |
Last Updated: December 28, 2025, 3:31 am
Below is a detailed analysis of the quarterly data for Aplab Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:
- For Sales, as of Sep 2025, the value is 17.35 Cr.. The value appears strong and on an upward trend. It has increased from 15.45 Cr. (Jun 2025) to 17.35 Cr., marking an increase of 1.90 Cr..
- For Expenses, as of Sep 2025, the value is 14.29 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 13.71 Cr. (Jun 2025) to 14.29 Cr., marking an increase of 0.58 Cr..
- For Operating Profit, as of Sep 2025, the value is 3.06 Cr.. The value appears strong and on an upward trend. It has increased from 1.74 Cr. (Jun 2025) to 3.06 Cr., marking an increase of 1.32 Cr..
- For OPM %, as of Sep 2025, the value is 17.64%. The value appears strong and on an upward trend. It has increased from 11.26% (Jun 2025) to 17.64%, marking an increase of 6.38%.
- For Other Income, as of Sep 2025, the value is 0.08 Cr.. The value appears to be declining and may need further review. It has decreased from 0.19 Cr. (Jun 2025) to 0.08 Cr., marking a decrease of 0.11 Cr..
- For Interest, as of Sep 2025, the value is 0.95 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 0.68 Cr. (Jun 2025) to 0.95 Cr., marking an increase of 0.27 Cr..
- For Depreciation, as of Sep 2025, the value is 0.11 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 0.12 Cr. (Jun 2025) to 0.11 Cr., marking a decrease of 0.01 Cr..
- For Profit before tax, as of Sep 2025, the value is 2.08 Cr.. The value appears strong and on an upward trend. It has increased from 1.13 Cr. (Jun 2025) to 2.08 Cr., marking an increase of 0.95 Cr..
- For Tax %, as of Sep 2025, the value is 22.60%. The value appears to be improving (decreasing) as expected. It has decreased from 24.78% (Jun 2025) to 22.60%, marking a decrease of 2.18%.
- For Net Profit, as of Sep 2025, the value is 1.61 Cr.. The value appears strong and on an upward trend. It has increased from 0.85 Cr. (Jun 2025) to 1.61 Cr., marking an increase of 0.76 Cr..
- For EPS in Rs, as of Sep 2025, the value is 0.64. The value appears strong and on an upward trend. It has increased from 0.34 (Jun 2025) to 0.64, marking an increase of 0.30.
Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.
Profit & Loss - Annual Report
Last Updated: December 15, 2025, 4:13 am
| Metric | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 94.86 | 74.18 | 70.89 | 72.04 | 61.03 | 53.19 | 51.47 | 53.02 | 51.36 | 51.48 | 49.05 | 63.67 | 72.67 |
| Expenses | 82.20 | 76.93 | 76.44 | 74.36 | 65.02 | 55.68 | 47.45 | 47.75 | 44.42 | 45.27 | 44.52 | 71.64 | 77.27 |
| Operating Profit | 12.66 | -2.75 | -5.55 | -2.32 | -3.99 | -2.49 | 4.02 | 5.27 | 6.94 | 6.21 | 4.53 | -7.97 | -4.60 |
| OPM % | 13.35% | -3.71% | -7.83% | -3.22% | -6.54% | -4.68% | 7.81% | 9.94% | 13.51% | 12.06% | 9.24% | -12.52% | -6.33% |
| Other Income | 0.93 | 0.71 | 0.82 | 1.55 | 0.38 | 18.50 | 3.42 | 1.32 | -1.08 | -1.72 | 0.24 | 5.09 | 3.42 |
| Interest | 10.22 | 10.63 | 11.24 | 11.21 | 10.82 | 8.06 | 6.21 | 6.60 | 5.31 | 3.84 | 3.53 | 3.20 | 3.35 |
| Depreciation | 2.78 | 1.76 | 1.62 | 1.56 | 1.44 | 1.29 | 1.02 | 0.38 | 0.38 | 0.45 | 0.44 | 0.49 | 0.46 |
| Profit before tax | 0.59 | -14.43 | -17.59 | -13.54 | -15.87 | 6.66 | 0.21 | -0.39 | 0.17 | 0.20 | 0.80 | -6.57 | -4.99 |
| Tax % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 18.77% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | -103.96% | |
| Net Profit | 0.59 | -14.43 | -17.59 | -13.54 | -15.87 | 5.41 | 0.21 | -0.39 | 0.17 | 0.20 | 0.80 | 0.26 | 1.09 |
| EPS in Rs | 0.30 | -7.22 | -8.80 | -6.77 | -7.94 | 2.70 | 0.10 | -0.20 | 0.08 | 0.10 | 0.36 | 0.10 | 0.43 |
| Dividend Payout % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
YoY Net Profit Growth
| Year | 2014-2015 | 2015-2016 | 2016-2017 | 2017-2018 | 2018-2019 | 2019-2020 | 2020-2021 | 2021-2022 | 2022-2023 | 2023-2024 | 2024-2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| YoY Net Profit Growth (%) | -2545.76% | -21.90% | 23.02% | -17.21% | 134.09% | -96.12% | -285.71% | 143.59% | 17.65% | 300.00% | -67.50% |
| Change in YoY Net Profit Growth (%) | 0.00% | 2523.86% | 44.92% | -40.23% | 151.30% | -230.21% | -189.60% | 429.30% | -125.94% | 282.35% | -367.50% |
Aplab Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 11 years from 2014-2015 to 2024-2025.
Growth
| Compounded Sales Growth | |
|---|---|
| 10 Years: | -2% |
| 5 Years: | 4% |
| 3 Years: | 7% |
| TTM: | 37% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 7% |
| 5 Years: | 16% |
| 3 Years: | -45% |
| TTM: | -42% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 19% |
| 5 Years: | 61% |
| 3 Years: | 73% |
| 1 Year: | 22% |
| Return on Equity | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| Last Year: | 3% |
Last Updated: September 5, 2025, 2:21 pm
Balance Sheet
Last Updated: December 4, 2025, 2:23 am
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Sep 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 5.00 | 5.00 | 5.00 | 5.00 | 5.00 | 5.00 | 5.00 | 5.00 | 10.00 | 10.00 | 11.09 | 12.57 | 15.71 |
| Reserves | 21.84 | 7.02 | -10.57 | -23.03 | -37.54 | -31.64 | -31.38 | -31.08 | -30.76 | -29.81 | -3.83 | -2.19 | 3.20 |
| Borrowings | 74.85 | 72.78 | 71.71 | 66.30 | 70.28 | 70.20 | 71.36 | 71.71 | 47.62 | 50.24 | 28.84 | 29.93 | 26.81 |
| Other Liabilities | 48.83 | 42.05 | 65.49 | 70.61 | 68.55 | 59.67 | 48.54 | 43.90 | 39.54 | 45.08 | 35.24 | 29.65 | 22.78 |
| Total Liabilities | 150.52 | 126.85 | 131.63 | 118.88 | 106.29 | 103.23 | 93.52 | 89.53 | 66.40 | 75.51 | 71.34 | 69.96 | 68.50 |
| Fixed Assets | 57.68 | 55.04 | 53.33 | 51.61 | 16.78 | 4.26 | 3.70 | 3.47 | 6.54 | 7.37 | 7.03 | 6.72 | 6.69 |
| CWIP | 0.00 | 0.00 | 0.00 | 0.35 | 0.82 | 2.35 | 3.59 | 3.88 | 1.08 | 0.00 | 0.49 | 1.21 | 1.09 |
| Investments | 2.26 | 0.07 | 0.07 | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 | 0.03 | 0.03 |
| Other Assets | 90.58 | 71.74 | 78.23 | 66.90 | 88.67 | 96.60 | 86.21 | 82.16 | 58.76 | 68.12 | 63.80 | 62.00 | 60.69 |
| Total Assets | 150.52 | 126.85 | 131.63 | 118.88 | 106.29 | 103.23 | 93.52 | 89.53 | 66.40 | 75.51 | 71.34 | 69.96 | 68.50 |
Below is a detailed analysis of the balance sheet data for Aplab Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:
- For Equity Capital, as of Sep 2025, the value is 15.71 Cr.. The value appears strong and on an upward trend. It has increased from 12.57 Cr. (Mar 2025) to 15.71 Cr., marking an increase of 3.14 Cr..
- For Reserves, as of Sep 2025, the value is 3.20 Cr.. The value appears strong and on an upward trend. It has increased from -2.19 Cr. (Mar 2025) to 3.20 Cr., marking an increase of 5.39 Cr..
- For Borrowings, as of Sep 2025, the value is 26.81 Cr.. The value appears to be improving (decreasing). However, Borrowings exceed Reserves, which may signal higher financial risk. It has decreased from 29.93 Cr. (Mar 2025) to 26.81 Cr., marking a decrease of 3.12 Cr..
- For Other Liabilities, as of Sep 2025, the value is 22.78 Cr.. The value appears to be improving (decreasing). It has decreased from 29.65 Cr. (Mar 2025) to 22.78 Cr., marking a decrease of 6.87 Cr..
- For Total Liabilities, as of Sep 2025, the value is 68.50 Cr.. The value appears to be improving (decreasing). It has decreased from 69.96 Cr. (Mar 2025) to 68.50 Cr., marking a decrease of 1.46 Cr..
- For Fixed Assets, as of Sep 2025, the value is 6.69 Cr.. The value appears to be declining and may need further review. It has decreased from 6.72 Cr. (Mar 2025) to 6.69 Cr., marking a decrease of 0.03 Cr..
- For CWIP, as of Sep 2025, the value is 1.09 Cr.. The value appears to be declining and may need further review. It has decreased from 1.21 Cr. (Mar 2025) to 1.09 Cr., marking a decrease of 0.12 Cr..
- For Investments, as of Sep 2025, the value is 0.03 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 0.03 Cr..
- For Other Assets, as of Sep 2025, the value is 60.69 Cr.. The value appears to be declining and may need further review. It has decreased from 62.00 Cr. (Mar 2025) to 60.69 Cr., marking a decrease of 1.31 Cr..
- For Total Assets, as of Sep 2025, the value is 68.50 Cr.. The value appears to be declining and may need further review. It has decreased from 69.96 Cr. (Mar 2025) to 68.50 Cr., marking a decrease of 1.46 Cr..
However, the Borrowings (26.81 Cr.) are higher than the Reserves (3.20 Cr.), which may signal higher financial risk.
Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.
Cash Flow
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Free Cash Flow
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow | -62.19 | -75.53 | -77.26 | -68.62 | -74.27 | -72.69 | -67.34 | -66.44 | -40.68 | -44.03 | -24.31 | -37.90 |
Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)
Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.
Financial Efficiency Indicators
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 109.66 | 90.00 | 102.77 | 88.92 | 36.42 | 131.89 | 134.24 | 104.71 | 124.51 | 212.92 | 169.22 | 124.51 |
| Inventory Days | 288.61 | 275.19 | 152.39 | 102.72 | 168.84 | 184.91 | 301.69 | 243.23 | 300.66 | 544.09 | 663.21 | 193.62 |
| Days Payable | 198.46 | 103.01 | 192.21 | 18.98 | 156.27 | 152.70 | 164.50 | 167.18 | 129.08 | 194.05 | 190.71 | 98.96 |
| Cash Conversion Cycle | 199.81 | 262.18 | 62.95 | 172.66 | 48.99 | 164.11 | 271.42 | 180.76 | 296.09 | 562.96 | 641.72 | 219.18 |
| Working Capital Days | -122.51 | -170.15 | -426.01 | -462.58 | -255.08 | -276.61 | -328.98 | -320.05 | -293.58 | -194.91 | 3.13 | -17.26 |
| ROCE % | 11.00% | -4.08% | -8.40% | -4.91% | -11.74% | -8.51% | 7.41% | 13.71% | 18.98% | 21.64% | 14.91% | -8.82% |
This stock is not held by any mutual fund.
Key Financial Ratios
| Month | Mar 16 | Mar 15 | Mar 14 | Mar 13 | Mar 12 |
|---|---|---|---|---|---|
| FaceValue | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| Basic EPS (Rs.) | -35.15 | -28.42 | 1.69 | -28.12 | -3.61 |
| Diluted EPS (Rs.) | -35.15 | -28.42 | 1.69 | -28.12 | -3.61 |
| Cash EPS (Rs.) | -31.37 | -24.41 | 7.54 | -23.24 | 1.60 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | -8.81 | 26.34 | 55.53 | 47.41 | 43.80 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | -8.77 | 26.39 | 55.59 | 47.47 | 44.03 |
| Revenue From Operations / Share (Rs.) | 142.20 | 149.14 | 191.06 | 142.68 | 194.29 |
| PBDIT / Share (Rs.) | -8.88 | -3.06 | 28.21 | -5.09 | 19.70 |
| PBIT / Share (Rs.) | -12.66 | -7.08 | 22.36 | -9.97 | 14.50 |
| PBT / Share (Rs.) | -35.14 | -28.33 | 1.91 | -28.17 | -3.48 |
| Net Profit / Share (Rs.) | -35.15 | -28.42 | 1.69 | -28.12 | -3.59 |
| NP After MI And SOA / Share (Rs.) | -35.15 | -28.42 | 1.69 | -28.12 | -3.59 |
| PBDIT Margin (%) | -6.24 | -2.05 | 14.76 | -3.56 | 10.13 |
| PBIT Margin (%) | -8.90 | -4.74 | 11.70 | -6.99 | 7.46 |
| PBT Margin (%) | -24.70 | -18.99 | 1.00 | -19.74 | -1.79 |
| Net Profit Margin (%) | -24.71 | -19.05 | 0.88 | -19.70 | -1.85 |
| NP After MI And SOA Margin (%) | -24.71 | -19.05 | 0.88 | -19.70 | -1.85 |
| Return on Networth / Equity (%) | 0.00 | -112.18 | 3.09 | -60.09 | -8.24 |
| Return on Capital Employeed (%) | -87.40 | -8.90 | 22.07 | -10.19 | 21.15 |
| Return On Assets (%) | -13.14 | -11.07 | 0.56 | -10.59 | -1.53 |
| Long Term Debt / Equity (X) | 0.00 | 0.58 | 0.46 | 0.57 | 0.43 |
| Total Debt / Equity (X) | -16.98 | 5.50 | 2.67 | 2.90 | 2.75 |
| Asset Turnover Ratio (%) | 0.54 | 0.53 | 0.67 | 0.57 | 0.81 |
| Current Ratio (X) | 0.39 | 0.57 | 0.67 | 0.74 | 0.96 |
| Quick Ratio (X) | 0.24 | 0.20 | 0.31 | 0.22 | 0.34 |
| Inventory Turnover Ratio (X) | 1.65 | 1.25 | 1.24 | 0.68 | 1.19 |
| Interest Coverage Ratio (X) | -0.39 | -0.14 | 1.38 | -0.27 | 1.10 |
| Interest Coverage Ratio (Post Tax) (X) | -0.56 | -0.33 | 1.08 | -0.56 | 0.80 |
| Enterprise Value (Cr.) | 88.89 | 87.10 | 88.96 | 75.60 | 70.92 |
| EV / Net Operating Revenue (X) | 1.25 | 1.17 | 0.93 | 1.06 | 0.73 |
| EV / EBITDA (X) | -20.01 | -56.88 | 6.31 | -29.70 | 7.20 |
| MarketCap / Net Operating Revenue (X) | 0.15 | 0.19 | 0.16 | 0.15 | 0.13 |
| Price / BV (X) | -2.24 | 1.16 | 0.57 | 0.45 | 0.61 |
| Price / Net Operating Revenue (X) | 0.15 | 0.19 | 0.16 | 0.15 | 0.13 |
| EarningsYield | -1.60 | -0.96 | 0.05 | -1.31 | -0.13 |
After reviewing the key financial ratios for Aplab Ltd, here is a detailed analysis based on the latest available data and recent trends:
- For FaceValue, as of Mar 16, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 15) which recorded 10.00.
- For Basic EPS (Rs.), as of Mar 16, the value is -35.15. This value is below the healthy minimum of 5. It has decreased from -28.42 (Mar 15) to -35.15, marking a decrease of 6.73.
- For Diluted EPS (Rs.), as of Mar 16, the value is -35.15. This value is below the healthy minimum of 5. It has decreased from -28.42 (Mar 15) to -35.15, marking a decrease of 6.73.
- For Cash EPS (Rs.), as of Mar 16, the value is -31.37. This value is below the healthy minimum of 3. It has decreased from -24.41 (Mar 15) to -31.37, marking a decrease of 6.96.
- For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 16, the value is -8.81. It has decreased from 26.34 (Mar 15) to -8.81, marking a decrease of 35.15.
- For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 16, the value is -8.77. It has decreased from 26.39 (Mar 15) to -8.77, marking a decrease of 35.16.
- For Revenue From Operations / Share (Rs.), as of Mar 16, the value is 142.20. It has decreased from 149.14 (Mar 15) to 142.20, marking a decrease of 6.94.
- For PBDIT / Share (Rs.), as of Mar 16, the value is -8.88. This value is below the healthy minimum of 2. It has decreased from -3.06 (Mar 15) to -8.88, marking a decrease of 5.82.
- For PBIT / Share (Rs.), as of Mar 16, the value is -12.66. This value is below the healthy minimum of 0. It has decreased from -7.08 (Mar 15) to -12.66, marking a decrease of 5.58.
- For PBT / Share (Rs.), as of Mar 16, the value is -35.14. This value is below the healthy minimum of 0. It has decreased from -28.33 (Mar 15) to -35.14, marking a decrease of 6.81.
- For Net Profit / Share (Rs.), as of Mar 16, the value is -35.15. This value is below the healthy minimum of 2. It has decreased from -28.42 (Mar 15) to -35.15, marking a decrease of 6.73.
- For NP After MI And SOA / Share (Rs.), as of Mar 16, the value is -35.15. This value is below the healthy minimum of 2. It has decreased from -28.42 (Mar 15) to -35.15, marking a decrease of 6.73.
- For PBDIT Margin (%), as of Mar 16, the value is -6.24. This value is below the healthy minimum of 10. It has decreased from -2.05 (Mar 15) to -6.24, marking a decrease of 4.19.
- For PBIT Margin (%), as of Mar 16, the value is -8.90. This value is below the healthy minimum of 10. It has decreased from -4.74 (Mar 15) to -8.90, marking a decrease of 4.16.
- For PBT Margin (%), as of Mar 16, the value is -24.70. This value is below the healthy minimum of 10. It has decreased from -18.99 (Mar 15) to -24.70, marking a decrease of 5.71.
- For Net Profit Margin (%), as of Mar 16, the value is -24.71. This value is below the healthy minimum of 5. It has decreased from -19.05 (Mar 15) to -24.71, marking a decrease of 5.66.
- For NP After MI And SOA Margin (%), as of Mar 16, the value is -24.71. This value is below the healthy minimum of 8. It has decreased from -19.05 (Mar 15) to -24.71, marking a decrease of 5.66.
- For Return on Networth / Equity (%), as of Mar 16, the value is 0.00. This value is below the healthy minimum of 15. It has increased from -112.18 (Mar 15) to 0.00, marking an increase of 112.18.
- For Return on Capital Employeed (%), as of Mar 16, the value is -87.40. This value is below the healthy minimum of 10. It has decreased from -8.90 (Mar 15) to -87.40, marking a decrease of 78.50.
- For Return On Assets (%), as of Mar 16, the value is -13.14. This value is below the healthy minimum of 5. It has decreased from -11.07 (Mar 15) to -13.14, marking a decrease of 2.07.
- For Long Term Debt / Equity (X), as of Mar 16, the value is 0.00. This value is below the healthy minimum of 0.2. It has decreased from 0.58 (Mar 15) to 0.00, marking a decrease of 0.58.
- For Total Debt / Equity (X), as of Mar 16, the value is -16.98. This value is within the healthy range. It has decreased from 5.50 (Mar 15) to -16.98, marking a decrease of 22.48.
- For Asset Turnover Ratio (%), as of Mar 16, the value is 0.54. It has increased from 0.53 (Mar 15) to 0.54, marking an increase of 0.01.
- For Current Ratio (X), as of Mar 16, the value is 0.39. This value is below the healthy minimum of 1.5. It has decreased from 0.57 (Mar 15) to 0.39, marking a decrease of 0.18.
- For Quick Ratio (X), as of Mar 16, the value is 0.24. This value is below the healthy minimum of 1. It has increased from 0.20 (Mar 15) to 0.24, marking an increase of 0.04.
- For Inventory Turnover Ratio (X), as of Mar 16, the value is 1.65. This value is below the healthy minimum of 4. It has increased from 1.25 (Mar 15) to 1.65, marking an increase of 0.40.
- For Interest Coverage Ratio (X), as of Mar 16, the value is -0.39. This value is below the healthy minimum of 3. It has decreased from -0.14 (Mar 15) to -0.39, marking a decrease of 0.25.
- For Interest Coverage Ratio (Post Tax) (X), as of Mar 16, the value is -0.56. This value is below the healthy minimum of 3. It has decreased from -0.33 (Mar 15) to -0.56, marking a decrease of 0.23.
- For Enterprise Value (Cr.), as of Mar 16, the value is 88.89. It has increased from 87.10 (Mar 15) to 88.89, marking an increase of 1.79.
- For EV / Net Operating Revenue (X), as of Mar 16, the value is 1.25. This value is within the healthy range. It has increased from 1.17 (Mar 15) to 1.25, marking an increase of 0.08.
- For EV / EBITDA (X), as of Mar 16, the value is -20.01. This value is below the healthy minimum of 5. It has increased from -56.88 (Mar 15) to -20.01, marking an increase of 36.87.
- For MarketCap / Net Operating Revenue (X), as of Mar 16, the value is 0.15. This value is below the healthy minimum of 1. It has decreased from 0.19 (Mar 15) to 0.15, marking a decrease of 0.04.
- For Price / BV (X), as of Mar 16, the value is -2.24. This value is below the healthy minimum of 1. It has decreased from 1.16 (Mar 15) to -2.24, marking a decrease of 3.40.
- For Price / Net Operating Revenue (X), as of Mar 16, the value is 0.15. This value is below the healthy minimum of 1. It has decreased from 0.19 (Mar 15) to 0.15, marking a decrease of 0.04.
- For EarningsYield, as of Mar 16, the value is -1.60. This value is below the healthy minimum of 5. It has decreased from -0.96 (Mar 15) to -1.60, marking a decrease of 0.64.
Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.
Strength and Weakness
| Strength | Weakness |
|---|---|
|
|
Stock Analysis
- Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Aplab Ltd:
- Net Profit Margin: -24.71%
- Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
- ROCE: -87.4% (Industry Average ROCE: 8.82%)
- ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
- ROE%: 0% (Industry Average ROE: 2.95%)
- ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
- Interest Coverage Ratio (Post Tax): -0.56
- Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
- Quick Ratio: 0.24
- Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
- Stock P/E: 163 (Industry average Stock P/E: 163)
- Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
- Total Debt / Equity: -16.98
- Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
Stock Rating: - Net Profit Margin: -24.71%
About the Company - Qualitative Analysis
| INDUSTRY | ADDRESS | CONTACT |
|---|---|---|
| Instrumentation & Process Control | Plot No. 12, TTC Industrial Area Thane Belapur Road, Digha, New Mumbai Maharashtra 400708 | Contact not found |
| Management | |
|---|---|
| Name | Position Held |
| Mrs. Amrita P Deodhar | Chairperson & Managing Director |
| Mr. S K Hajela | Additional Director |
| Mr. Sanjay N Mehta | Independent Director |
| Mrs. Uma Balakrishnan | Independent Director |
FAQ
What is the intrinsic value of Aplab Ltd?
Aplab Ltd's intrinsic value (as of 05 January 2026) is ₹29.55 which is 62.02% lower the current market price of ₹77.80, indicating overvalued. Calculated using the PE ratio method, this valuation considers the company's ₹178 Cr. market cap, FY2025-2026 high/low of ₹93.0/28.2, reserves of ₹3.20 Cr, and liabilities of ₹68.50 Cr.
What is the Market Cap of Aplab Ltd?
The Market Cap of Aplab Ltd is 178 Cr..
What is the current Stock Price of Aplab Ltd as on 05 January 2026?
The current stock price of Aplab Ltd as on 05 January 2026 is ₹77.8.
What is the High / Low of Aplab Ltd stocks in FY 2025-2026?
In FY 2025-2026, the High / Low of Aplab Ltd stocks is ₹93.0/28.2.
What is the Stock P/E of Aplab Ltd?
The Stock P/E of Aplab Ltd is 163.
What is the Book Value of Aplab Ltd?
The Book Value of Aplab Ltd is 7.53.
What is the Dividend Yield of Aplab Ltd?
The Dividend Yield of Aplab Ltd is 0.00 %.
What is the ROCE of Aplab Ltd?
The ROCE of Aplab Ltd is 8.82 %.
What is the ROE of Aplab Ltd?
The ROE of Aplab Ltd is 2.95 %.
What is the Face Value of Aplab Ltd?
The Face Value of Aplab Ltd is 10.0.